display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic, hormone-sensitive prostate cancer
metastatic, hormone-sensitive prostate cancer
darolutamide plus doxetaxel plus ADT ARASENS

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons